Clinical Trials

Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 141 - 160 of 447 trials
Titlesort icon Investigator Disease(s)
A Phase III Study of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy in Patients with Cutaneous Melanomas that Have Metastasized to the Sentinel Node
[Protocol 09-112] 		Ariyan, Charlotte
  • Melanoma
A Phase III Study of Sapacitabine in Elderly Patients Newly Diagnosed with Acute Myeloid Leukemia
[Protocol 12-034] 		Berman, Ellin
  • Geriatrics
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase III Study of Rituximab/Lenalidomide or Rituximab/Chemotherapy Followed by Rituximab Maintenance Therapy in Patients with Previously Untreated Follicular Lymphoma
[Protocol 12-081] 		Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Rituximab plus GS-1101 (CAL-101) or Placebo for Previously Treated Chronic Lymphocytic Leukemia
[Protocol 12-160] 		Zelenetz, Andrew
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120] 		Kaley, Thomas
  • Brain Tumors, Primary
    • Gliomas
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase III Study of ProstAtakTM as an Adjuvant to Up-front Radiation Therapy for Localized Prostate Cancer
[Protocol 11-172] 		Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081] 		Lee, Nancy
  • Head & Neck Cancer
A Phase III Study of Ponatinib versus Imatinib for Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
[Protocol 12-216] 		Berman, Ellin
  • Leukemia
    • Chronic Myelocytic Leukemia
A Phase III Study of Pazopanib as Adjuvant Therapy for Patients with Localized or Locally Advanced Renal Cell Carcinoma Following Nephrectomy
[Protocol 10-162] 		Motzer, Robert
  • Kidney Cancer
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] 		Hensley, Martee
  • Endometrial and other Uterine Cancers
    • Uterine Cancer
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
[Protocol 11-079] 		Matasar, Matthew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Nilotinib (Tasigna®) versus Dacarbazine in Patients with Advanced Melanoma with a c-Kit Mutation (TEAM Trial
[Protocol 10-102] 		Carvajal, Richard
  • Melanoma
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041] 		Eastham, James
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072] 		Dunkel, Ira
  • Retinoblastoma
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018] 		Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128] 		Klimek, Virginia
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007] 		Moskowitz, Alison
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Inotuzumab Ozogamicin with Rituximab versus Standard Therapy for Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
[Protocol 12-005] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
[Protocol 12-061] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118] 		Lake, Diana
  • Breast Cancer
On Our Blog